Journey Medical Corporation — Cash Flow (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -2.18 M-13.53 M5.24 M-9.13 M-12.44 M -12.44 M Cash from investing activities -10 M-20 M-5 M-15 M-94 K -94 K Cash from financing activities 53.02 M16.46 M-4.8 M16.99 M16.23 M 16.23 M Free cash flow -12.18 M-33.53 M240 K-24.13 M-27.44 M -12.44 M

뉴스

Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

B.Riley, Journey Medical에 ’매수’ 등급 유지, 목표가 12달러 유지

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

미노사이클린, 16주 사용 후 미생물군집 파괴 없어

Minocycline study shows no microbiome disruption after 16-week use

포트리스 바이오텍, 멘케스병 치료제 NDA 재신청 보고

Journey Medical Q3 실적, 수익 에상치보다 저조

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Cisco, Flutter, Manulife and more set to report earnings Wednesday